cMET in NSCLC: Can We Cut off the Head of the Hydra? From the Pathway to the Resistance.

Van Der Steen, Nele; Pauwels, Patrick; Gil-Bazo, Ignacio; Castañon, Eduardo; Raez, Luis; Cappuzzo, Federico; Rolfo, Christian.

Afiliação

Van Der Steen N; Center for Oncological Research Antwerp, University of Antwerp, Universiteitsplein 1, Wilrijk 2610, Belgium. Nele.VanDerSteen@uantwerpen.be.
Pauwels P; Center for Oncological Research Antwerp, University of Antwerp, Universiteitsplein 1, Wilrijk 2610, Belgium. Patrick.Pauwels@uza.be.
Gil-Bazo I; Molecular Pathology Unit, Pathology Department, Antwerp University Hospital, Wilrijkstraat 10, Edegem 2650, Belgium. Patrick.Pauwels@uza.be.
Castañon E; Department of Oncology, Clínica Universidad de Navarra, Pamplona 31008, Spain.
Raez L; Department of Oncology, Clínica Universidad de Navarra, Pamplona 31008, Spain. ecastanon@unav.es.
Cappuzzo F; Phase I-Early Clinical Trials Unit, Oncology Department, Antwerp University Hospital, Wilrijkstraat 10, Edegem 2650, Belgium. ecastanon@unav.es.
Rolfo C; Thoracic Oncology Program, Memorial Cancer Institute, Memorial Health Care System, Pembroke Pines, FL 33024, USA. lraez@mhs.net.

Cancers (Basel) ; 7(2): 556-73, 2015 Mar 25.

Article em En | MEDLINE | ID: mdl-25815459

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2015 Tipo de documento: Article